These should also show up on Ibotta & Fetch, reader Bockrr was able to turn this into an $8 money maker. You can read more about Aisle here. Find more Aisle deals here.
UGC NET Management Paper 2 | UGC NET Management Unit 1 | Business Management UGC NET By Yogita Mam | UGC NET Management Preparation | UGC NET Management Syllabus 2026 | UGC NET Management Marathon | UGC NET Management Paper 1 | UGC NET Management Paper 2 Full Course | UGC NET Management Books | UGC NET Management PYQ
Playlist:
In this video, Yogita Ma’am covers Business Management from Unit 1 of UGC NET Management Paper 2 with important concepts, management theories, functions of management, PYQs, and exam-oriented MCQs. 📈🔥 This session is बेहद important for aspirants preparing for UGC NET Management 2026 who want strong conceptual clarity and better score in Management Paper 2.
Topics Covered:
🔹 UGC NET Management Paper 2
🔹 UGC NET Management Preparation
🔹 UGC NET Management Marathon
🔹 UGC NET Management Syllabus 2026
🔹UGC NET Management PYQ
🔹UGC NET Management Paper 2 Full Course
👉Foundation Batch 1.0🔥UGC NET DEC 2026 –
📲Special🔥Offer Click here:
🔴 For Admission Call Us: 08045888812
🎓Qualified? Ab Assistant Professor ki bari Fill the Form:
🎓Qualified? Ab Assistant Professor ki bari:
────────────────────────────────────────
🔴Join Yogita Mam Testbook Telegram channel:
➡️ Use this Coupon Code to get Extra Discount : YOGITA
➡️Join Free Masterclass on Testbook App at 3:00 PM :
🔴Download Testbook App:
🔴Official Telegram channel:
🔴Visit our website:
🔴Follow Us on Instagram:
UGC NET Exam
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
The National Educational Testing Bureau of University Grants Commission (UGC) conducts National Eligibility Test (NET) to determine eligibility for lectureship and for award of Junior Research Fellowship (JRF) for Indian nationals in order to ensure minimum standards for the entrants in the teaching profession.
Related Queries
ugc net management
ugc net management paper 2
ugc net management preparation
ugc net management marathon
ugc net management paper 2 full course
ugc net management books
ugc net management pyq
ugc net management paper 2 marathon
#ugcnet #ugcnetmanagement #ugcnetpaper2 #ugcnetexam #ugcnetjune2026 #ugcnetjrf #ugcnettestbook #ugcnetmanagementpaper2
source
Extinction is the Easy Story for AI
Starting this week, all of Robinhood’s roughly 29 million customers will have access to trading agents powered by OpenAI and Anthropic. Customers will be able to choose between various OpenAI and Anthropic models, and instruct the agents to carry out trades, conduct research, and build complex investment strategies.
The rollout, which coincided with Robinhood’s annual HOOD summit, follows a move by the company in May to release a so-called MCP tool that allows technical users to hook up their own agents to its trading platform.
While AI has been creeping into every corner of finance, Robinhood is the first to release a nontechnical trading agent for a giant customer base—a step that has the potential to alter how Americans invest, and that could have ripple effects on markets more broadly.
In a demonstration viewed by Fortune, a Robinhood user was invited to give their agent a name, and then choose either OpenAI’s GPT-6 Luna, its GPT-6 Sol, or Anthropic’s Opus 4.8.
Once configured, the user could then provide plain English instructions to the agent, which was able to execute tasks ranging from simple trades like “Buy $200 of Ford stock” to more complex assignments like “Loops.” As Robinhood explains, “you can set a Loop to check the market every morning and execute a trade when certain conditions are met, or run a continuous overnight strategy to look for opportunities while you sleep.”
Robinhood’s new offering also comes with a series of guardrails that the company says will prevent agents from behaving in an unexpected manner. Those include providing a dedicated trading account for the agent, and letting users set limits on how much the agent can trade at a time. Users can also opt for a confirmation process that requires the agents to seek final approval before executing a transaction.
The Robinhood Agents service will also provide users with free access to a series of data providers, such as Unusual Whales and the crypto-focused Token Terminal, for a limited period.
In conversations with Fortune, Robinhood executives made the case that access to easy-to-use agents, as well as libraries of financial data, will provide users with investing tools comparable to the ones used by Wall Street. If this is the case, the arrival of Robinhood Agents amounts to another milestone in the company’s self-proclaimed mission to democratize finance.
“Ownership doesn’t work without markets, and markets don’t work without traders,” said Robinhood CEO Vlad Tenev in a statement. “We’re making Robinhood the best place in the world for active traders by delivering tools once reserved for hedge funds, big banks, and quant firms.”
At the same time, the mass release of trading agents has the potential to change investment patterns in unpredictable ways. That could include a major uptick in the volume of active trading on exchanges or the emergence of new trading strategies.
It’s possible to imagine hypothetical future scenarios that are less rosy. For instance, what if trading agents begin to confer with one another, and move en masse into or out of a given asset? Such a scenario could, in turn, introduce greater volatility into the market or even outright panic if they involve malicious actors.
In the event that something does go wrong with agent-based trading, it’s unclear where any legal liability would fall. Robinhood’s view is that hosting agents does not amount to providing financial advice and that, when it comes to any suggestions they provide or actions they undertake, the situation is akin to the customers asking the internet or a friend. Like so much with AI, however, the legal landscape around agentic trading is still evolving.
There is also the question of how much customers end up spending to operate their trading agents. For its rollout period, Robinhood plans to offer the lower-end GPT-6 Luna for free until the end of the year, and charge the standard token rate to use the OpenAI and Anthropic agents. Company executives say that the cost of using the agents for most transactions will be negligible, but it remains to be seen if that will be the case should the cost of compute rise unexpectedly, or if large numbers of customers pursue research intense trading strategies.
There is also the question of how many investors will actually use the agents for trading in the first place. There are early signs, though, that they will. According to Robinhood, over 150,000 customers have already opened agentic accounts by using the more technical version of the tool the company introduced this spring. And as of late September, various agents are transacting on Robinhood’s platform nearly 30 million times a day.
While Robinhood is for now the only brokerage to offer nontechnical agents at scale, other fintech and crypto firms—including eToro, Public, and Coinbase—currently let their users connect their agents via MCP tools. It is a likely bet that these firms will soon roll out trading agents directly within their own platforms, and that, in time, conventional brokerages like Schwab and Fidelity will do the same.
In the near future, it is easy to imagine an environment where agents are placing billions of trades a day, and where ordinary investors are deploying elaborate strategies in the new corners of the market. How this affects market performance and wealth accumulation remains to be seen.
September 29, 2026
Known for surprising its customers with hand-painted portraits of a pet or handwritten condolence cards, Chewy has earned an almost unparalleled level of customer trust and loyalty. But how will the company adapt as the customer experience is increasingly mediated by AI?
SoFi, Mastercard partner on card payment stablecoin settlement The system connects blockchain-based settlement and established card infrastructure. Stablecoins will settle transactions within the normal card experience. Moov Money built on Visa, Mastercard rails Moov Money enables consumers to send and receive money through their existing… Read More
Updated StatCan estimates erase most of the previously reported population decline, strengthening the case that rising supply helped drive asking rents lower.
Opinions expressed by Entrepreneur contributors are their own.
A few months ago, Oxylabs landed a $130 million investment from Warburg Pincus, pushing our valuation to $3.6 billion — the highest ever recorded in the public web data sector, and our first outside capital in more than a decade of doing business.
Back in 2015, when Oxylabs was launched, few had heard about automated web data access as a separate industry, and even fewer understood the underlying technology. There was no rulebook to follow, no regulatory framework that clearly applied and no seasoned executives to consult on intractable problems.
Technology develops fast, and today there are plenty of similar avenues for innovation and companies carving out their own niche. So here are simple but hard-won lessons for everyone trying to build a category-defining company in an emerging, stormy industry.
Succeeding in a new industry requires a two-fold approach — frequent, bold experimentation and a dependable core product. To figure out what works, you need to be willing to try many different things, many of which will fail. But you can only afford some turbulence and freedom to experiment if the value of your core offering is unshakeable.
Customers will understand a few misfires, especially if you are building on top of novel solutions. But competitors can pop up just as quickly as client patience runs out when workflows or data pipelines break and cause significant downtime.
Experimenting and innovating is something you must do to claim your place in an emerging industry. Just as important is setting up a patenting system as early as possible. Next to your ingenious engineers, you need capable lawyers who will make their work worth that much more. Proprietary knowledge that no one cares about today will be priceless when everyone else starts to notice the opportunity in your sector.
Beyond the legal protection, a proactive approach to patents forces your team to articulate exactly what’s proprietary and defensible about their approach in the first place. That clarity, in turn, helps you build a strategy to pre-empt — or at least soften — any disputes that arise later on.
It might be tempting to treat the absence of clear regulation as an absence of responsibility. Prioritizing growth, revenue and competitive edge makes sense for an emerging company in an unclaimed industry. But if you are in for the long run, act like it from the get-go. Rigorous know-your-customer checks, use-case vetting and data protection should become part of your company’s culture from day one, even when it means turning away opportunities or moving slower than less scrupulous competitors.
Trust built this way compounds over time. It gives credibility to attract investors and a solid backbone to pass due diligence. Importantly, if you are in an industry no one understands, and many assume it is shady, audits or regulatory inquiries will come without you doing anything wrong. Prejudice is only overcome by proof of responsible conduct.
A company can only outrun its industry’s reputation for so long. When shady players shape how regulators, the media and the public view a new category, every honest business in that category ends up paying for it. That’s why it often falls to the more responsible players to work together and lead the way. Joining or starting industry associations that set and promote common standards, and that certify companies willing to be held to them, is something companies can do without waiting for outside regulation.
In the web data industry, no such body existed until a group of companies came together to launch the Ethical Web Data Collection Initiative. It’s hard to build trust in your own business if the entire category is seen as untrustworthy, so investing in your industry’s credibility is one of the most impactful things a leader in the field can do.
Growing at a pace your infrastructure and compliance standards can support takes real discipline. Enticing offers might come early on. Capital investment early on gives you a head start, resources and time in the sun. But it can also become a burden.
Being fiscally responsible lets you raise funds only when you can do so on your own terms. Similarly, while acquiring a competitor has the appeal of a power move, it doesn’t necessarily make sense in current market conditions. Don’t buy just to demonstrate growth and attract investor attention. Buy to expand your market presence and product offering, and the investors will come to you.
Building without a map is hard — failure lurks around any corner, and success is hard to envision, let alone reach. But being among the first also means you have plenty of room where you can build. And you get to help set the terms for how your industry operates and in what light it is judged. That kind of foundational work pays off down the line.
A few months ago, Oxylabs landed a $130 million investment from Warburg Pincus, pushing our valuation to $3.6 billion — the highest ever recorded in the public web data sector, and our first outside capital in more than a decade of doing business.
Back in 2015, when Oxylabs was launched, few had heard about automated web data access as a separate industry, and even fewer understood the underlying technology. There was no rulebook to follow, no regulatory framework that clearly applied and no seasoned executives to consult on intractable problems.
Technology develops fast, and today there are plenty of similar avenues for innovation and companies carving out their own niche. So here are simple but hard-won lessons for everyone trying to build a category-defining company in an emerging, stormy industry.
The Shiller CAPE Ratio is at its second-highest reading in 150 years. The last time it was this high was right before the dot-com bubble burst, with the S&P 500 Index (^GSPC -0.17%) crashing nearly 50% over the next two and a half years. That elevated market valuation indicator has me looking for more safe investments.
I came across Pfizer (PFE +0.00%) while screening for quality dividend stocks to buy amid the current market environment. While its high 6% yield initially looked like a trap, the more I dig into Pfizer, the more I see a potential safety net for a looming market storm.
Image source: The Motley Fool.
American economist Robert Shiller invented the CAPE ratio (cyclically adjusted price-to-earnings ratio) to gauge whether the S&P 500 is currently undervalued or overvalued relative to its inflation-adjusted earnings over the last 10 years.
This ratio peaked in December 1999 at 44.2. The S&P 500 would go on to peak shortly thereafter and endure one of the biggest stock market crashes in history.
Its next-highest point before this year came in October 2021, when it hit 38.6. The following year, the S&P 500 tumbled 25% from peak to trough.
Given this historical precedent, I’m looking for safe investments to hold during a potential market downturn.
I’m going to start with the negatives. Pfizer is facing several headwinds, including patent expirations, tariffs, and declining sales of its COVID-19 products. Through the first six months of this year, its revenues have only risen 4% to $29.5 billion, while its adjusted earnings fell 10% to $1.52 per share.
Today’s Change
(0.00%) $0.00
Current Price
$28.72
Market Cap
Day’s Range
$28.26 – $28.76
52wk Range
$23.62 – $29.21
Volume
32.5M
Avg Vol
38M
Gross Margin
64.83%
Dividend Yield
5.99%
The company isn’t currently covering its dividend with cash flow. Last year, Pfizer generated $11.7 billion in net cash provided by operating activities, while paying $9.8 billion in dividends. However, it also invested $2.6 billion in capex, leaving it with a $700 million shortfall to cover with its balance sheet. Pfizer also spent $6.9 billion on acquisitions, which it funded with its balance sheet. Meanwhile, it has generated only $3.4 billion in cash from operating activities through the first half of this year, not nearly enough to cover the $4.9 billion it paid in dividends. The company’s declining earnings and cash flow shortfalls certainly put the dividend at risk.
Healthcare stocks are typically recession-resilient investments because people can’t defer most healthcare spending. As a result, healthcare companies generally generate more durable cash flows and have strong balance sheets.
Pfizer has a fortress balance sheet. It currently has A/A2 credit ratings with a stable outlook from both rating agencies. The company ended the second quarter with $11.7 billion of cash and short-term investments on its balance sheet against $63.2 billion of debt, a comfortable level for a $163 billion company by market cap.
Meanwhile, the company is taking actions to improve its cash flow and reinvigorate growth. Pfizer currently plans to deliver $9.7 billion in total net savings through 2029 via its cost realignment and manufacturing optimization programs. Additionally, it’s investing heavily in R&D and acquisitions to drive growth. Recently launched or acquired products drove an 18% increase in operational revenue last quarter. These initiatives are part of Pfizer’s strategy to deliver high-single-digit five-year compound annual revenue growth after 2028. This strategy supports its plan to maintain and grow the dividend while deleveraging its balance sheet over time.
Pfizer’s current struggles have weighed on its valuation. It trades at just 9.5 times forward earnings. That’s a bargain compared to the S&P 500, which trades at nearly 20 times forward earnings. Pfizer’s low valuation is why it has such a high dividend yield.
Pfizer looks like a value in today’s pricy market. Meanwhile, investors are well paid while they wait for the company to turn around its operations, which is already underway, as recently acquired and launched products are driving growth. While Pfizer’s turnaround makes it riskier than other dividend stocks, its low valuation means it offers more ballast and long-term upside potential than most stocks in today’s seemingly overvalued market.
Saving money is important, but is it enough to build wealth? In this episode of Cele’s Reflections, we sit down with financial expert Susan Wanjiku to break down basic investments simply and practically, from emergency funds to money market funds, SACCOs, shares, and bonds. We unpack where beginners can start without feeling overwhelmed. We also discuss common mistakes people make, why consistency matters more than large amounts, and how to move from just saving to actually growing your money. If you have been wondering how to start investing this year, this conversation will give you clarity and confidence to begin
Get the Budget Tracker at a 20% Discount Here:
YouTube: @thelegacyhubke
Don’t forget to like, comment, and subscribe for more episodes every Wednesday!
Thanks for watching!
source
